EUVIMEDEUVIMED entdecken
Open Access

Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes

Michael T Wotman iD, Tara Ivic-Pavlicic, William H Westra, Brandon Gold, Megan D'Andrea, Eric M Genden, Krzysztof Misiukiewicz, Scott A Roof, Emanuela Taioli iD, Marshall Posner

The Oncologist · 2024

DOI: 10.1093/oncolo/oyae202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2024. Verfasst von Michael T Wotman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Genotype, Papillomavirus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Tisch Cancer Institute at Mount Sinai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human papillomavirus (HPV)+ oropharynx cancer (OPC) has a more favorable prognosis than HPV-negative disease, but the impact of specific HPV genotype and phylogenic clade on patient outcomes is not well understood and has profound implications for treatment de-intensification.

Methods

The objective of this single-institution cohort study was to investigate the association of HPV genotype (16 vs high-risk non-16) and clade (A9 vs A7) with OPC outcomes. The primary endpoints were overall survival (OS) and event-free survival (EFS) in patients with M0 disease treated with curative intent.

Results

The cohort included 598 patients (87% HPV16, 98% A9). Compared to those with HPV16 OPC, individuals with non-HPV16 OPC had a higher age, comorbidity index, and proportion of non-whites, HIV+ patients, T4 tumors, and stage IV disease (AJCC 7th edition). Non-HPV16 genotype was associated with worse OS in univariate (HR = 2.17, 95% CI, 1.24-3.80, P = .0066), but not in multivariate analysis (HRadj = 0.84, 95% CI, 0.43-1.62, P = .5921). A7 clade was associated with worse OS in univariate (HR = 4.42, 95% CI, 1.60-12.30, P = .0041), but not in multivariate analysis (HRadj = 2.39, 95% CI, 0.57-9.99, P = .2325). Neither HPV genotype (HR = 1.60, 95% CI, 0.99-2.60, P = .0566) nor phylogenic clade (HR = 2.47, 95% CI, 0.91-6.72, P = .0761) was associated with EFS.

Conclusion

Non-HPV16 genotype and A7 clade were associated with worse OS and trended toward worse EFS in univariate analyses. The survival differences were more pronounced by phylogenic clade than by HPV16 status, suggesting that the former may be a more useful classification for future studies. However, neither HPV16 status nor phylogenic clade was prognostic when adjusting for patient and tumor covariates, raising the question as to whether possible differences in outcomes are related to distinct clinical profiles rather than inherent viral properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsGenotypePapillomavirus InfectionsHumansFemaleMaleMiddle AgedAgedPapillomaviridaePhylogenyPrognosisAdultCohort StudiesAged, 80 and overHuman papillomavirus 16Human Papillomavirus Viruses

Stichwörter der Autor:innen

cladegenotypeoropharyngeal neoplasmspapillomaviridaesurvival analysis

Autor:innen und Institutionen

  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
  • Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
  • Department of Otolaryngology, Rutgers New Jersey Medical School, Newark, NJ 07103, United States.
  • Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
  • Department of Otolaryngology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.

ORCID-Profile: Michael T Wotman, Emanuela Taioli

Förderung

  • Tisch Cancer Institute at Mount Sinai

Zitieren

APA

Wotman, M. T., Ivic-Pavlicic, T., Westra, W. H., Gold, B., D'Andrea, M., Genden, E. M., Misiukiewicz, K., Roof, S. A., Taioli, E., & Posner, M. (2024). Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes. The Oncologist. https://doi.org/10.1093/oncolo/oyae202

Vancouver

Wotman MT, Ivic-Pavlicic T, Westra WH, Gold B, D'Andrea M, Genden EM, et al. Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes. The Oncologist. 2024. doi:10.1093/oncolo/oyae202

BibTeX
@article{Wotman2024,
  author = {Wotman, Michael T and Ivic-Pavlicic, Tara and Westra, William H and Gold, Brandon and D'Andrea, Megan and Genden, Eric M and Misiukiewicz, Krzysztof and Roof, Scott A and Taioli, Emanuela and Posner, Marshall},
  title = {Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes},
  journal = {The Oncologist},
  year = {2024},
  doi = {10.1093/oncolo/oyae202}
}
Kostenlos starten →